CWCaitlin S. Williamson

Caitlin S. Williamson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Caitlin S. Williamson has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ULK1-Dependent Autophagy Initiation Promotes MHC-I Degradation and Immune Evasion in HPV-Positive Head and Neck Cancer

    by Lexi Vu, Nicholas S. Giacobbi, Mohamed I. Khalil, Canchai Yang, William J. Eckerman, Evelyn D. Gomez Recinos, Johnathon D. Garber, Abigail Z. Bennett, Bryttan Adams, Hyomin Son, et al.

    Antigen presentation by MHC class I (MHC-I) is critical for tumor cell killing by CD8+ T cells. In human papillomavirus–positive head and neck cancer (HPV+ HNC), in which MHC-I downregulation is frequent despite favorable immune cell infiltration, lower MHC-I levels are associated with poor responses to immune checkpoint inhibitor therapy. However, the mechanism of MHC-I degradation remains elusive. Genome-wide CRISPR screens in HPV+ HNC identified components of the ULK1 and PIK3C3 autophagy initiation complexes among top negative regulators of cell surface MHC-I. In contrast, inhibiting postinitiation stages of autophagy did not restore cell surface MHC-I, highlighting a critical role for autophagy initiation in regulation of MHC-I. Mechanistically, we showed that MHC-I is recruited from the endoplasmic reticulum to autophagosomes by the cargo receptor NDP52. Finally, inhibition of autophagy initiation suppressed HPV+ HNC tumor growth in vivo and enhanced the CD8+ T cell–mediated antitumor response. Our findings suggest that autophagic degradation of MARCHF8-ubiquitinated MHC-I is a key immune evasion mechanism in HPV+ HNC.

  • Open Access

    Functional neuronal circuits promote disease progression in cancer

    by Anthony C. Restaino, Austin Walz, Samuel J. Vermeer, Jeffrey Barr, Attila Kovács, Robin R. Fettig, Daniel W. Vermeer, Hunter Reavis, Caitlin S. Williamson, Christopher T. Lucido, et al.

    The molecular and functional contributions of intratumoral nerves to disease remain largely unknown. We localized synaptic markers within tumors suggesting that these nerves form functional connections. Consistent with this, electrophysiological analysis shows that malignancies harbor significantly higher electrical activity than benign disease or normal tissues. We also demonstrate pharmacologic silencing of tumoral electrical activity. Tumors implanted in transgenic animals lacking nociceptor neurons show reduced electrical activity. These data suggest that intratumoral nerves remain functional at the tumor bed. Immunohistochemical staining demonstrates the presence of the neuropeptide, Substance P (SP), within the tumor space. We show that tumor cells express the SP receptor, NK1R, and that ligand/receptor engagement promotes cellular proliferation and migration. Our findings identify a mechanism whereby intratumoral nerves promote cancer progression.